Detalhe da pesquisa
1.
A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma.
Oncologist
; 29(4): 278-288, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207010
2.
Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic Leukemia.
Value Health
; 25(10): 1685-1695, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537984
3.
Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.
Support Care Cancer
; 30(3): 2755-2766, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825982
4.
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies.
Br J Haematol
; 193(1): 15-25, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216986
5.
Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
Blood
; 133(16): 1742-1752, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803990
6.
Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
Ann Hematol
; 100(10): 2501-2512, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34279676
7.
Same-day versus next-day pegfilgrastim or pegfilgrastim-cbqv in patients with lymphoma receiving CHOP-like chemotherapy.
Future Oncol
; 17(26): 3485-3497, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34241542
8.
Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience.
Support Care Cancer
; 29(8): 4867-4874, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547525
9.
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Br J Haematol
; 191(1): 44-51, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430944
10.
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Oncologist
; 25(10): 878-885, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720734
11.
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Oncologist
; 25(6): e993-e997, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275786
12.
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
Oncologist
; 24(11): e1236-e1250, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346132
13.
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.
Cancer
; 124(15): 3192-3200, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797667
14.
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
Oncology
; 94(5): 274-280, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29471300
15.
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Am J Hematol
; 93(4): 486-493, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266344
16.
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.
Blood
; 125(2): 236-41, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395425
17.
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001.
Haematologica
; 107(11): 2732-2736, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833300
18.
A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma.
Oncology
; 93(6): 401-405, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869931
19.
Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI.
Mol Imaging
; 152016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27140422
20.
Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review.
Biol Blood Marrow Transplant
; 22(7): 1182-1196, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26899562